$OXFD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Oxford Immunotec Global PLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Oxford Immunotec Global PLC. Get notifications about new insider transactions in Oxford Immunotec Global PLC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 05 2017 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 15.82 | 3,000 | 47,460 | 15,000 | 18 K to 15 K (-16.67 %) |
Sep 05 2017 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Buy | M | 0.81 | 3,000 | 2,430 | 18,000 | 15 K to 18 K (+20.00 %) |
Aug 30 2017 | OXFD | Oxford Immunotec G ... | Linn Stefan C | Chief Operating Off ... | Option Exercise | A | 15.37 | 71,942 | 1,105,749 | 71,942 | |
Aug 30 2017 | OXFD | Oxford Immunotec G ... | Linn Stefan C | Chief Operating Off ... | Grant | A | 0.00 | 32,531 | 0 | 32,531 | 0 to 32.5 K |
Aug 16 2017 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Sell | S | 16.14 | 9,739 | 157,171 | 92,905 | 102.6 K to 92.9 K (-9.49 %) |
Aug 09 2017 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Sell | S | 17.70 | 22,371 | 395,971 | 102,644 | 125 K to 102.6 K (-17.89 %) |
Jul 26 2017 | OXFD | Oxford Immunotec G ... | Wenstrup Richard | Chief Medical Offic ... | Option Exercise | A | 16.11 | 61,920 | 997,531 | 61,920 | |
Jul 26 2017 | OXFD | Oxford Immunotec G ... | Wenstrup Richard | Chief Medical Offic ... | Grant | A | 0.00 | 18,622 | 0 | 18,622 | 0 to 18.6 K |
Jul 10 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 27,168 | 22,006 | 149,273 | |
Jul 10 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 15.94 | 27,168 | 433,006 | 461,668 | 488.8 K to 461.7 K (-5.56 %) |
Jul 10 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 27,168 | 22,006 | 488,836 | 461.7 K to 488.8 K (+5.88 %) |
Jul 07 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 16,394 | 13,279 | 176,441 | |
Jul 07 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 16,438 | 13,315 | 0 | |
Jul 07 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 16.58 | 16,394 | 271,849 | 461,668 | 478.1 K to 461.7 K (-3.43 %) |
Jul 07 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 16,394 | 13,279 | 478,062 | 461.7 K to 478.1 K (+3.55 %) |
Jul 07 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 16.58 | 16,438 | 272,578 | 461,668 | 478.1 K to 461.7 K (-3.44 %) |
Jul 07 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 16,438 | 13,315 | 478,106 | 461.7 K to 478.1 K (+3.56 %) |
Jun 29 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 30,000 | 24,300 | 16,438 | |
Jun 29 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 16.06 | 30,000 | 481,797 | 461,668 | 491.7 K to 461.7 K (-6.10 %) |
Jun 29 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 30,000 | 24,300 | 491,668 | 461.7 K to 491.7 K (+6.50 %) |
Jun 16 2017 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | Senior VP & General ... | Sell | S | 15.01 | 4,085 | 61,305 | 25,393 | 29.5 K to 25.4 K (-13.86 %) |
Jun 13 2017 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | Senior VP & General ... | Payment of Exercise | F | 14.63 | 1,136 | 16,620 | 29,478 | 30.6 K to 29.5 K (-3.71 %) |
Jun 08 2017 | OXFD | Oxford Immunotec G ... | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 14.46 | 7,457 | 107,828 | 7,457 | |
Jun 08 2017 | OXFD | Oxford Immunotec G ... | BALTHROP PATRICK J | Director | Option Exercise | A | 14.46 | 7,457 | 107,828 | 7,457 | |
Jun 08 2017 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Option Exercise | A | 14.46 | 7,457 | 107,828 | 7,457 | |
Jun 08 2017 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Director | Option Exercise | A | 14.46 | 7,457 | 107,828 | 7,457 | |
Jun 08 2017 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Option Exercise | A | 14.46 | 7,457 | 107,828 | 7,457 | |
Jun 08 2017 | OXFD | Oxford Immunotec G ... | Spotts Stephen L | Director | Option Exercise | A | 14.46 | 7,457 | 107,828 | 7,457 | |
Jun 08 2017 | OXFD | Oxford Immunotec G ... | TOBIN JAMES R | Director | Option Exercise | A | 14.46 | 7,457 | 107,828 | 7,457 | |
Jun 08 2017 | OXFD | Oxford Immunotec G ... | Walton Andrew Scott | Director | Option Exercise | A | 14.46 | 7,457 | 107,828 | 7,457 | |
Jun 01 2017 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Gift | G | 0.00 | 2,174 | 0 | 15,000 | 17.2 K to 15 K (-12.66 %) |
May 16 2017 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Sell | S | 14.66 | 10,000 | 146,572 | 125,015 | 135 K to 125 K (-7.41 %) |
May 11 2017 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Option Exercise | M | 0.81 | 3,000 | 2,430 | 5,778 | |
May 11 2017 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.40 | 3,000 | 43,200 | 17,174 | 20.2 K to 17.2 K (-14.87 %) |
May 11 2017 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Buy | M | 0.81 | 3,000 | 2,430 | 20,174 | 17.2 K to 20.2 K (+17.47 %) |
May 10 2017 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Sell | S | 14.01 | 22,397 | 313,854 | 127,147 | 149.5 K to 127.1 K (-14.98 %) |
May 10 2017 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Sell | S | 14.30 | 17,603 | 251,806 | 149,544 | 167.1 K to 149.5 K (-10.53 %) |
Apr 21 2017 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Option Exercise | M | 0.26 | 21,460 | 5,580 | 0 | |
Apr 21 2017 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Option Exercise | M | 0.09 | 22,371 | 2,013 | 0 | |
Apr 21 2017 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Option Exercise | M | 0.09 | 42,913 | 3,862 | 0 | |
Apr 21 2017 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Buy | M | 0.26 | 21,460 | 5,580 | 135,015 | 113.6 K to 135 K (+18.90 %) |
Apr 21 2017 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Buy | M | 0.09 | 22,371 | 2,013 | 113,555 | 91.2 K to 113.6 K (+24.53 %) |
Apr 21 2017 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Buy | M | 0.09 | 42,913 | 3,862 | 91,184 | 48.3 K to 91.2 K (+88.90 %) |
Apr 05 2017 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Option Exercise | M | 0.09 | 22,371 | 2,013 | 0 | |
Apr 05 2017 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Option Exercise | M | 0.09 | 42,804 | 3,852 | 51,000 | |
Apr 05 2017 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Buy | M | 0.09 | 22,371 | 2,013 | 167,147 | 144.8 K to 167.1 K (+15.45 %) |
Apr 05 2017 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Buy | M | 0.09 | 42,804 | 3,852 | 144,776 | 102 K to 144.8 K (+41.98 %) |
Apr 05 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 30,000 | 24,300 | 46,438 | |
Apr 05 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 15.43 | 30,000 | 463,005 | 461,668 | 491.7 K to 461.7 K (-6.10 %) |
Apr 05 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 30,000 | 24,300 | 491,668 | 461.7 K to 491.7 K (+6.50 %) |
Apr 05 2017 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 15.47 | 3,000 | 46,420 | 17,174 | 20.2 K to 17.2 K (-14.87 %) |
Mar 22 2017 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | Senior VP & General ... | Option Exercise | M | 0.81 | 8,185 | 6,630 | 0 | |
Mar 22 2017 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | Senior VP & General ... | Option Exercise | M | 0.81 | 3,000 | 2,430 | 8,185 | |
Mar 22 2017 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | Senior VP & General ... | Buy | M | 0.81 | 8,185 | 6,630 | 30,614 | 22.4 K to 30.6 K (+36.49 %) |
Mar 22 2017 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | Senior VP & General ... | Sell | S | 16.05 | 3,000 | 48,150 | 22,429 | 25.4 K to 22.4 K (-11.80 %) |
Mar 22 2017 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | Senior VP & General ... | Buy | M | 0.81 | 3,000 | 2,430 | 25,429 | 22.4 K to 25.4 K (+13.38 %) |
Mar 06 2017 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Option Exercise | A | 13.50 | 31,650 | 427,275 | 31,650 | |
Mar 06 2017 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Sell | S | 14.92 | 5,923 | 88,382 | 48,271 | 54.2 K to 48.3 K (-10.93 %) |
Mar 06 2017 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Grant | A | 0.00 | 6,968 | 0 | 54,194 | 47.2 K to 54.2 K (+14.75 %) |
Mar 06 2017 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | VP & General Counse ... | Option Exercise | A | 13.50 | 26,661 | 359,924 | 26,661 | |
Mar 06 2017 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | VP & General Counse ... | Grant | A | 0.00 | 5,870 | 0 | 22,429 | 16.6 K to 22.4 K (+35.45 %) |
Mar 06 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | A | 13.50 | 105,255 | 1,420,943 | 105,255 | |
Mar 06 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Grant | A | 0.00 | 23,173 | 0 | 461,668 | 438.5 K to 461.7 K (+5.28 %) |
Mar 06 2017 | OXFD | Oxford Immunotec G ... | Altieri Richard M. | Chief Financial Off ... | Option Exercise | A | 13.50 | 38,838 | 524,313 | 38,838 | |
Mar 06 2017 | OXFD | Oxford Immunotec G ... | Altieri Richard M. | Chief Financial Off ... | Grant | A | 0.00 | 8,551 | 0 | 52,893 | 44.3 K to 52.9 K (+19.28 %) |
Mar 06 2017 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Option Exercise | A | 13.50 | 39,683 | 535,721 | 39,683 | |
Mar 06 2017 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Grant | A | 0.00 | 8,737 | 0 | 101,972 | 93.2 K to 102 K (+9.37 %) |
Feb 07 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 25,000 | 20,250 | 76,438 | |
Feb 07 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 13.36 | 25,000 | 333,875 | 438,495 | 463.5 K to 438.5 K (-5.39 %) |
Feb 07 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 25,000 | 20,250 | 463,495 | 438.5 K to 463.5 K (+5.70 %) |
Jan 04 2017 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Payment of Exercise | F | 14.95 | 1,706 | 25,505 | 47,226 | 48.9 K to 47.2 K (-3.49 %) |
Jan 04 2017 | OXFD | Oxford Immunotec G ... | Altieri Richard M. | Chief Financial Off ... | Payment of Exercise | F | 14.95 | 1,038 | 15,518 | 44,342 | 45.4 K to 44.3 K (-2.29 %) |
Jan 04 2017 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Option Exercise | M | 0.09 | 22,371 | 2,013 | 0 | |
Jan 04 2017 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Option Exercise | M | 0.09 | 13,783 | 1,240 | 0 | |
Jan 04 2017 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Buy | M | 0.09 | 22,371 | 2,013 | 93,235 | 70.9 K to 93.2 K (+31.57 %) |
Jan 04 2017 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Buy | M | 0.09 | 13,783 | 1,240 | 70,864 | 57.1 K to 70.9 K (+24.15 %) |
Jan 04 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Payment of Exercise | F | 14.95 | 4,819 | 72,044 | 438,495 | 443.3 K to 438.5 K (-1.09 %) |
Dec 20 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 7,052 | 5,712 | 101,438 | |
Dec 20 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 15.07 | 7,052 | 106,241 | 443,314 | 450.4 K to 443.3 K (-1.57 %) |
Dec 20 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 7,052 | 5,712 | 450,366 | 443.3 K to 450.4 K (+1.59 %) |
Dec 07 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 1,140 | 923 | 108,490 | |
Dec 07 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 15.00 | 1,140 | 17,100 | 443,314 | 444.5 K to 443.3 K (-0.26 %) |
Dec 07 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 1,140 | 923 | 444,454 | 443.3 K to 444.5 K (+0.26 %) |
Dec 05 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 1,000 | 810 | 109,630 | |
Dec 05 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 19,925 | 16,139 | 110,630 | |
Dec 05 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 15.00 | 1,000 | 15,000 | 443,314 | 444.3 K to 443.3 K (-0.23 %) |
Dec 05 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 1,000 | 810 | 444,314 | 443.3 K to 444.3 K (+0.23 %) |
Dec 05 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 15.00 | 60,808 | 912,120 | 443,314 | 504.1 K to 443.3 K (-12.06 %) |
Dec 05 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 19,925 | 16,139 | 504,122 | 484.2 K to 504.1 K (+4.12 %) |
Nov 16 2016 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Sell | S | 14.09 | 4,869 | 68,615 | 48,932 | 53.8 K to 48.9 K (-9.05 %) |
Nov 09 2016 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.17 | 9,500 | 134,568 | 20,174 | 29.7 K to 20.2 K (-32.01 %) |
Nov 09 2016 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.15 | 200 | 2,830 | 29,674 | 29.9 K to 29.7 K (-0.67 %) |
Nov 09 2016 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.20 | 400 | 5,680 | 29,874 | 30.3 K to 29.9 K (-1.32 %) |
Nov 09 2016 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.17 | 1,500 | 21,255 | 30,274 | 31.8 K to 30.3 K (-4.72 %) |
Nov 09 2016 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.19 | 400 | 5,674 | 31,774 | 32.2 K to 31.8 K (-1.24 %) |
Jun 29 2016 | OXFD | Oxford Immunotec G ... | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 8.65 | 7,457 | 64,503 | 7,457 | |
Jun 29 2016 | OXFD | Oxford Immunotec G ... | Walton Andrew Scott | Director | Option Exercise | A | 8.65 | 7,457 | 64,503 | 7,457 | |
Jun 29 2016 | OXFD | Oxford Immunotec G ... | BALTHROP PATRICK J | Director | Option Exercise | A | 8.65 | 7,457 | 64,503 | 7,457 | |
Jun 29 2016 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Option Exercise | A | 8.65 | 7,457 | 64,503 | 7,457 | |
Jun 29 2016 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Director | Option Exercise | A | 8.65 | 7,457 | 64,503 | 7,457 | |
Jun 29 2016 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Option Exercise | A | 8.65 | 7,457 | 64,503 | 7,457 | |
Jun 29 2016 | OXFD | Oxford Immunotec G ... | Spotts Stephen L | Director | Option Exercise | A | 8.65 | 7,457 | 64,503 | 7,457 | |
Jun 29 2016 | OXFD | Oxford Immunotec G ... | TOBIN JAMES R | Director | Option Exercise | A | 8.65 | 7,457 | 64,503 | 7,457 | |
Mar 08 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | A | 10.21 | 128,959 | 1,316,671 | 128,959 | |
Mar 08 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Grant | A | 0.00 | 30,950 | 0 | 484,197 | 453.2 K to 484.2 K (+6.83 %) |
Mar 08 2016 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | VP & General Counse ... | Option Exercise | A | 10.21 | 31,495 | 321,564 | 31,495 | |
Mar 08 2016 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | VP & General Counse ... | Grant | A | 0.00 | 7,559 | 0 | 16,559 | 9 K to 16.6 K (+83.99 %) |
Mar 08 2016 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Option Exercise | A | 10.21 | 51,931 | 530,216 | 51,931 | |
Mar 08 2016 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Grant | A | 0.00 | 12,463 | 0 | 57,081 | 44.6 K to 57.1 K (+27.93 %) |
Mar 08 2016 | OXFD | Oxford Immunotec G ... | Altieri Richard M. | Chief Financial Off ... | Option Exercise | A | 10.21 | 40,812 | 416,691 | 40,812 | |
Mar 08 2016 | OXFD | Oxford Immunotec G ... | Altieri Richard M. | Chief Financial Off ... | Grant | A | 0.00 | 9,795 | 0 | 45,380 | 35.6 K to 45.4 K (+27.53 %) |
Mar 08 2016 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Option Exercise | A | 10.21 | 39,454 | 402,825 | 39,454 | |
Mar 08 2016 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Grant | A | 0.00 | 9,469 | 0 | 53,801 | 44.3 K to 53.8 K (+21.36 %) |
Feb 02 2016 | OXFD | Oxford Immunotec G ... | BALTHROP PATRICK J | Director | Option Exercise | A | 11.62 | 14,914 | 173,301 | 14,914 | |
Feb 02 2016 | OXFD | Oxford Immunotec G ... | BALTHROP PATRICK J | Director | Option Exercise | A | 11.62 | 3,728 | 43,319 | 3,728 | |
Jan 19 2016 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Option Exercise | M | 0.09 | 5,000 | 450 | 15,074 | |
Jan 19 2016 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Buy | M | 0.09 | 5,000 | 450 | 8,650 | 3.7 K to 8.7 K (+136.99 %) |
Nov 20 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.73 | 200 | 2,745 | 32,174 | 32.4 K to 32.2 K (-0.62 %) |
Nov 20 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.69 | 100 | 1,369 | 32,374 | 32.5 K to 32.4 K (-0.31 %) |
Nov 20 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.60 | 600 | 8,157 | 32,474 | 33.1 K to 32.5 K (-1.81 %) |
Nov 20 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.52 | 200 | 2,704 | 33,074 | 33.3 K to 33.1 K (-0.60 %) |
Nov 20 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.50 | 500 | 6,750 | 33,274 | 33.8 K to 33.3 K (-1.48 %) |
Nov 20 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.34 | 100 | 1,334 | 33,774 | 33.9 K to 33.8 K (-0.30 %) |
Nov 20 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.33 | 38 | 507 | 33,874 | 33.9 K to 33.9 K (-0.11 %) |
Nov 20 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.30 | 62 | 825 | 33,912 | 34 K to 33.9 K (-0.18 %) |
Nov 20 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.21 | 700 | 9,244 | 33,974 | 34.7 K to 34 K (-2.02 %) |
Nov 20 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.59 | 100 | 1,359 | 34,674 | 34.8 K to 34.7 K (-0.29 %) |
Nov 20 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.58 | 100 | 1,358 | 34,774 | 34.9 K to 34.8 K (-0.29 %) |
Nov 20 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.53 | 300 | 4,059 | 34,874 | 35.2 K to 34.9 K (-0.85 %) |
Nov 20 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.51 | 200 | 2,702 | 35,174 | 35.4 K to 35.2 K (-0.57 %) |
Nov 20 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.51 | 100 | 1,351 | 35,374 | 35.5 K to 35.4 K (-0.28 %) |
Nov 20 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.50 | 1,700 | 22,950 | 35,474 | 37.2 K to 35.5 K (-4.57 %) |
Nov 19 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.00 | 4,600 | 59,800 | 37,174 | 41.8 K to 37.2 K (-11.01 %) |
Nov 19 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.01 | 200 | 2,602 | 41,774 | 42 K to 41.8 K (-0.48 %) |
Nov 19 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.02 | 100 | 1,302 | 41,974 | 42.1 K to 42 K (-0.24 %) |
Nov 19 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.03 | 100 | 1,303 | 42,074 | 42.2 K to 42.1 K (-0.24 %) |
Nov 06 2015 | OXFD | Oxford Immunotec G ... | Walton Andrew Scott | Director | Option Exercise | A | 12.50 | 14,914 | 186,425 | 14,914 | |
Nov 06 2015 | OXFD | Oxford Immunotec G ... | Walton Andrew Scott | Director | Option Exercise | A | 12.50 | 7,457 | 93,213 | 7,457 | |
Nov 06 2015 | OXFD | Oxford Immunotec G ... | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 12.50 | 14,914 | 186,425 | 14,914 | |
Nov 06 2015 | OXFD | Oxford Immunotec G ... | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 12.50 | 7,457 | 93,213 | 7,457 | |
Aug 05 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.00 | 3,000 | 42,000 | 42,174 | 45.2 K to 42.2 K (-6.64 %) |
Jun 23 2015 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | A | 14.12 | 41,931 | 592,066 | 41,931 | |
Jun 23 2015 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Grant | A | 0.00 | 22,066 | 0 | 453,247 | 431.2 K to 453.2 K (+5.12 %) |
Jun 23 2015 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Option Exercise | A | 14.12 | 15,740 | 222,249 | 15,740 | |
Jun 23 2015 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Grant | A | 0.00 | 8,098 | 0 | 44,618 | 36.5 K to 44.6 K (+22.17 %) |
Jun 23 2015 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Option Exercise | A | 14.12 | 15,400 | 217,448 | 15,400 | |
Jun 23 2015 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Grant | A | 0.00 | 7,812 | 0 | 44,332 | 36.5 K to 44.3 K (+21.39 %) |
Jun 23 2015 | OXFD | Oxford Immunotec G ... | Altieri Richard M. | Chief Financial Off ... | Option Exercise | A | 14.12 | 12,288 | 173,507 | 12,288 | |
Jun 23 2015 | OXFD | Oxford Immunotec G ... | Altieri Richard M. | Chief Financial Off ... | Grant | A | 0.00 | 6,865 | 0 | 35,585 | 28.7 K to 35.6 K (+23.90 %) |
Jun 17 2015 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 14.30 | 39,701 | 567,724 | 2,237,377 | 2.3 M to 2.2 M (-1.74 %) |